Opexa Therapeutics Reports First Quarter 2015 Financial Results And Provides Corporate Update

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies including multiple sclerosis (MS) and neuromyelitis optica (NMO), today reported financial results for the three months ended March 31, 2015 and provided an update on the Company’s recent corporate developments.

Help employers find you! Check out all the jobs and post your resume.